Lupus Market Size, Share, Trends & Growth Opportunity [2031]

Lupus Market Size, Share, Trends & Growth Opportunity [2031]

Segments - Global Lupus Market by Techniques (Cutaneous Lupus Erythematosus, Drug-induced Lupus Erythematosus, Neonatal Lupus, and Systemic Lupus Erythematosus), Products (Antimalarial Drugs, Biologics, Corticosteroids, Immunosuppressants, Nonsteroidal Anti-inflammatory Drugs, and Others), End-users (Diagnostic Laboratories, Hospital & Clinics, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2023-2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4075 | 4.2 Rating | 60 Reviews | 187 Pages | Format : PDF Excel PPT

Report Description


Lupus Market Outlook 2031

The global lupus market size was  USD 3.30 Billion in 2022 and is estimated to reach USD 7.97 Billion by 2031 register a high CAGR 10.3% during the forecast period, between 2023 to 2031. Lupus is a chronic autoimmune disease that causes widespread inflammation throughout the body.

The immune system of patients suffering from the disease are normally weaken due to the attacks of the cells on its own tissues causing damage to the heart, kidney, brain, joints, skin, lungs, and blood vessels. It is a type of disease that can affect every organ of the patient body. Some of the major lupus symptoms include adnominal pain, arthritis, headaches, kidney disease, hair loss, rashes, and more. A patient's treatment and diagnosis is different depending on the type of lupus and the results of blood tests.   

Lupus Market Outlook

  • Rising prevalence of lupus as well as growing R&D activities to develop innovative treatment methods and techniques are key factors driving the market growth.
  • Growing awareness of the disease along with increasing demand for advanced lupus treatment and diagnostics act as major drivers of the market.
  • Stringent regulatory guidelines for approval of new drugs and high prices of lupus treatment drugs are expected to be major barriers to market expansion in the coming years.
  • Expansion of clinical trials, new product development, and combination therapy studies undertaken by key players are key growth opportunities of the market expansion in the coming years.

Scope of the Lupus Market Report:

The report on the global lupus market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Lupus Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016 - 2021

Forecast Period

2023–2031

Segmentation

Techniques (Cutaneous Lupus Erythematosus, Drug-induced Lupus Erythematosus, Neonatal Lupus, and Systemic Lupus Erythematosus), Products (Antimalarial Drugs, Biologics, Corticosteroids, Immunosuppressants, Nonsteroidal Anti-inflammatory Drugs, and Others), End-Users (Diagnostic Laboratories, Hospital & Clinics, and Others)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered

Aurinia Pharmaceuticals; F. Hoffmann-La; Bayer AG; GlaxoSmithKline plc; Mylan N.V.; Sandoz International GmbH; Bristol-Myers Squibb; Pfizer, Inc.; Cadila Healthcare; Sanofi; Lycera Corporation; Merck KGaA; Novartis AG; ImmuPharma LLC; and Trinity Biotech

Lupus Market Segment Insights:

Systemic lupus erythematosus segment to hold significant market share

Based on techniques, the global lupus market is segregated into cutaneous lupus erythematosus, drug-induced lupus erythematosus, neonatal lupus, and systemic lupus erythematosus. The systemic lupus erythematosus segment is projected to hold significant market share owing to wide adoption of the technique for the disease treatment.

This treatment can assist in managing symptoms and avoid other lupus-related health issues such as flare-ups. The involvement of large biopharmaceutical companies in drugs that are currently in clinical trials is likely to boost the segment growth in the coming years. Moreover, the growing burden of autoimmune diseases is a key driver of the segment.

Lupus Market Techinques

Biologics segment to account for a substantial share

On the basis of products, the market is segmented into antimalarial drugs, biologics, corticosteroids, immunosuppressants, nonsteroidal anti-inflammatory drugs, and others. The biologics segment is anticipated to account for a substantial share owing to the development of new biologics with better efficacy, such as Rituximab and Benlysta, and several biologics are currently in the final stages of development.

The immunosuppressants segment, however, is projected to expand at a robust growth pace in the coming years attributed to the widespread use of methotrexate due to its inexpensive prices of the product.

Hospitals & clinics segment to register a substantial growth rate

In terms of end-users, the global lupus market is segmented into diagnostic laboratories, hospital & clinics, and others. The hospitals & clinics segment is expected to register a substantial growth rate during the forecast period due to the increasing prevalence of the disease, extensive research activities, and wide testing in hospitals and clinics.

Moreover, the presence of medical experts in hospitals and clinics for the diagnosis of the disease present another key driver of the segment.  

Lupus Market End Users

North America is expected to dominate the market

In terms of regions, the market is classified as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market in the coming years due to the availability of reimbursement facility and citizens' increased expenditure on healthcare in the region.

Moreover, the rising prevalence of lupus, the growing demand for better treatment options, and government lupus initiatives are key aspects for the regional market growth. On the other hand, the market of Asia Pacific is anticipated to expand at a robust pace in the near future due to increasing number of people in high-income groups and rising government funding for research activities.

 Major biotechnology companies are currently outsourcing their product development services to countries such as India, Singapore, China, and Malaysia, which is propelling the market in this region.

Lupus Market Regions

Segments

 

By Techniques

  • Cutaneous Lupus Erythematosus
  • Drug-induced Lupus Erythematosus
  • Neonatal Lupus
  • Systemic Lupus Erythematosus

By Products

  • Antimalarial Drugs
  • Biologics
  • Corticosteroids
  • Immunosuppressants
  • Nonsteroidal Anti-inflammatory Drugs
  • Others

By End-Users

  • Diagnostic Laboratories
  • Hospital & Clinics
  • Others

By Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

By Key Players

  • Aurinia Pharmaceuticals
  • F. Hoffmann-La
  • Bayer AG
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Sandoz International GmbH
  • Bristol-Myers Squibb
  • Pfizer, Inc.
  • Cadila Healthcare
  • Sanofi
  • Lycera Corporation
  • Merck KGaA
  • Novartis AG
  • ImmuPharma LLC
  • Trinity Biotech

Competitive Landscape

Key players in the global lupus market are Aurinia Pharmaceuticals; F. Hoffmann-La; Bayer AG; GlaxoSmithKline plc; Mylan N.V.; Sandoz International GmbH; Bristol-Myers Squibb; Pfizer, Inc.; Cadila Healthcare; Sanofi; Lycera Corporation; Merck KGaA; Novartis AG; ImmuPharma LLC; and Trinity Biotech.

These players have widely engaged in various market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to strengthen their geographical presence and expand their customer base globally. 

Lupus Market key players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lupus Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Lupus Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Lupus Market - Supply Chain
  4.5. Global Lupus Market Forecast
     4.5.1. Lupus Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Lupus Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Lupus Market Absolute $ Opportunity
5. Global Lupus Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Lupus Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Lupus Demand Share Forecast, 2019-2026
6. North America Lupus Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Lupus Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Lupus Demand Share Forecast, 2019-2026
7. Latin America Lupus Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Lupus Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Lupus Demand Share Forecast, 2019-2026
8. Europe Lupus Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Lupus Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Lupus Demand Share Forecast, 2019-2026
9. Asia Pacific Lupus Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Lupus Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Lupus Demand Share Forecast, 2019-2026
10. Middle East & Africa Lupus Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Lupus Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Lupus Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Lupus Market: Market Share Analysis
  11.2. Lupus Distributors and Customers
  11.3. Lupus Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Aurinia Pharmaceuticals
     11.4.2. F. Hoffmann-La
     11.4.3. Bayer AG
     11.4.4. GlaxoSmithKline plc
     11.4.5. Mylan N.V.
     11.4.6. Sandoz International GmbH
     11.4.7. Bristol-Myers Squibb
     11.4.8. Pfizer,

Methodology

Our Clients

Deloitte
General Electric
Siemens Healthcare
Pfizer
Nestle SA
Honda Motor Co. Ltd.
General Mills
FedEx Logistics